Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCC® Probiotic and Influenza Vaccine Response
NCT00294788Phase 2Unknown
- Sponsor
- Probiomics
- Start
- Mar 2006
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of prothrombin complex concentrate, human in influenza, sponsored by Probiomics. Primary endpoint: Hemagglutination Inhibition Titre at 4 weeks. Status: unknown.
02
Drugs
prothrombin complex concentrate, human
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00294788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00294788.